Clinical Trial Update: Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of inhaled zanamivir for treating influenza A and B infections in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection

Drugs mentioned

• Zanamivir (Relenza) (Zanamivir)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Influenza A Virus Infection, Influenza B Virus Infection | Phase 3 | Status: COMPLETED